+ Follow REGIMEN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1541428
[Title] => Fitness Point
[Summary] => Zero One's "Fitness Point" is a multi-functional workout app that can either function as a handy workout regimen guide, a workout-performance tracker or as a companion app for personalized workout regimens.
[DatePublished] => 2016-01-10 09:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1794253
[AuthorName] => Yasunari Ramon Suarez Taguchi
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 506571
[Title] => New rabies vaccine requires only one shot: study
[Summary] => WASHINGTON (Xinhua) - A single shot of vaccine might soon be sufficient to provide protection against rabies, U.S. researchers reported on Friday.
[DatePublished] => 2009-09-19 23:00:25
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 502718
[Title] => Sports Nutrition
[Summary] => The only restaurant in Cebu I know that offers sports nutrition meals is the Old Spaghetti House in SM.
[DatePublished] => 2009-09-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1728377
[AuthorName] => Ruth Mercado
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[3] => Array
(
[ArticleID] => 473018
[Title] => Understanding the pain
[Summary] => CEBU, Philippines - Exercise buffs are all too familiar with it, but I would bet my license that they would never be comfortable if they ever get it.
[DatePublished] => 2009-06-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1702187
[AuthorName] => Ritche T. Salgado
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[4] => Array
(
[ArticleID] => 147970
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 147160
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[6] => Array
(
[ArticleID] => 146351
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 145601
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[8] => Array
(
[ArticleID] => 145284
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
REGIMEN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1541428
[Title] => Fitness Point
[Summary] => Zero One's "Fitness Point" is a multi-functional workout app that can either function as a handy workout regimen guide, a workout-performance tracker or as a companion app for personalized workout regimens.
[DatePublished] => 2016-01-10 09:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1794253
[AuthorName] => Yasunari Ramon Suarez Taguchi
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 506571
[Title] => New rabies vaccine requires only one shot: study
[Summary] => WASHINGTON (Xinhua) - A single shot of vaccine might soon be sufficient to provide protection against rabies, U.S. researchers reported on Friday.
[DatePublished] => 2009-09-19 23:00:25
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[2] => Array
(
[ArticleID] => 502718
[Title] => Sports Nutrition
[Summary] => The only restaurant in Cebu I know that offers sports nutrition meals is the Old Spaghetti House in SM.
[DatePublished] => 2009-09-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1728377
[AuthorName] => Ruth Mercado
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[3] => Array
(
[ArticleID] => 473018
[Title] => Understanding the pain
[Summary] => CEBU, Philippines - Exercise buffs are all too familiar with it, but I would bet my license that they would never be comfortable if they ever get it.
[DatePublished] => 2009-06-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1702187
[AuthorName] => Ritche T. Salgado
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[4] => Array
(
[ArticleID] => 147970
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 147160
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[6] => Array
(
[ArticleID] => 146351
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 145601
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[8] => Array
(
[ArticleID] => 145284
[Title] => US FDA Approves Single-Dose Treatment For Pediatric Ear Infections
[Summary] => NEW YORK -- Pfizer Inc said recently that the U.S. Food and Drug Administration has approved Zithromax (azithromycin for oral suspension) as both a single-dose regimen and a three-day regimen for the treatment of acute otitis media in pediatric patients.
Azithromycin for oral suspension as a single dose or three-day regimen provides a full course of therapy, while most currently available antibiotics require 10 days of multi-dose treatment. It has unique attributes that include high and sustained drug levels in infected tissues, which make short-course dosing possible.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
September 19, 2009 - 11:00pm
January 22, 2002 - 12:00am
January 15, 2002 - 12:00am
January 8, 2002 - 12:00am
January 1, 2002 - 12:00am
December 29, 2001 - 12:00am
